title: The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.
abstract: The tumor suppressor LKB1 gene encodes a serine-threonine kinase that regulates cell proliferation and polarity. Inactivation of LKB1 by mutations in LKB1 or loss of its expression is highly correlated with lung, ovarian, and pancreatic cancers, and WNT/β-catenin pathway is also known to be involved in many human malignancies. However, the relationship between LKB1 and WNT signaling pathway in esophageal carcinoma remains unknown. The expression of LKB1 in 62 cases of esophageal cancer patients was determined by quantitative real-time PCR. It was found that LKB1 mRNA level was significantly lower than the adjacent normal epithelium and that the LKB1 downregulation was correlating with TNM stages. Moreover, the expression of WNT target genes such as Cyclin D1, C-MYC, MMP2, and FZD2 was significantly upregulated in esophageal cancer tissues. LKB1 overexpression in TE10 cells inhibited TOPFlash luciferase reporter activity and WNT target gene expression even in the presence of WNT3A. Conversely, LKB1 knockdown enhanced WNT signaling activity in esophageal cancer cells. It was also found that LKB1 antagonized WNT signaling pathway through interaction with GSK3β to downregulate β-catenin expression level. Functional investigation revealed that LKB1 suppressed the promotion effects of WNT3A on the cell growth of TE10 cells. The LKB1 functions in regulating cell growth and WNT target genes expression were impaired by GSK3β inhibition, suggesting that LKB1 antagonized WNT-induced cell proliferation through enhancement of GSK3β activity. Together, the interaction between LKB1 and GSK3β upregulates GSK3β activity to suppress WNT-induced cell proliferation in esophageal carcinoma cells. Loss of LKB1 expression may result in the deregulation of WNT/β-catenin pathway to promote malignant progression of esophageal cancer.
authors.forename: Kai
authors.initials: K
authors.lastname: Liu
authors.forename: Yue
authors.initials: Y
authors.lastname: Luo
authors.forename: Hui
authors.initials: H
authors.lastname: Tian
authors.forename: Kai-Zhong
authors.initials: KZ
authors.lastname: Yu
authors.forename: Jin-Xian
authors.initials: JX
authors.lastname: He
authors.forename: Wei-Yu
authors.initials: WY
authors.lastname: Shen
mesh_terms: D000091162:AMP-Activated Protein Kinase Kinases; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000235:genetics / Q000378:metabolism; D004938:Esophageal Neoplasms / Q000235:genetics* / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D055785:Gene Knockdown Techniques; D038362:Glycogen Synthase Kinase 3 / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D008297:Male; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D060449:Wnt Signaling Pathway / Q000235:genetics*; D051176:beta Catenin / Q000096:biosynthesis / Q000378:metabolism
chemical_list: D051176:beta Catenin; D019938:Cyclin D1; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; D017346:Protein Serine-Threonine Kinases; C109790:STK11 protein, human; D038362:Glycogen Synthase Kinase 3; D000091162:AMP-Activated Protein Kinase Kinases
references.citation: Biochem Biophys Res Commun. 1994 Sep 15;203(2):1090-5
references.pmid: 8093026
references.citation: N Engl J Med. 2003 Mar 20;348(12):1177-9; author reply 1177-9
references.pmid: 12646678
references.citation: Curr Opin Cell Biol. 2013 Apr;25(2):254-64
references.pmid: 23347562
references.citation: Pathologe. 2013 Mar;34(2):148-54
references.pmid: 23420516
references.citation: Am J Pathol. 1999 Mar;154(3):677-81
references.pmid: 10079245
references.citation: Int J Cancer. 1996 Jun 21;69(3):225-35
references.pmid: 8682592
references.citation: Hum Mol Genet. 2005 Aug 1;14(15):2209-19
references.pmid: 15987703
references.citation: Cancer Res. 1998 May 15;58(10):2087-90
references.pmid: 9605748
references.citation: Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9026-30
references.pmid: 8415648
references.citation: Oncogene. 1999 Mar 4;18(9):1777-80
references.pmid: 10208439
references.citation: Surg Today. 2005;35(1):7-18
references.pmid: 15622457
references.citation: Nat Cell Biol. 2003 Oct;5(10):889-94
references.pmid: 12973359
references.citation: N Engl J Med. 2003 Mar 20;348(12):1177-9; author reply 1177-9
references.pmid: 12647729
references.citation: Genes Dev. 2000 Aug 1;14(15):1837-51
references.pmid: 10921899
references.citation: Am J Pathol. 2001 Dec;159(6):2017-22
references.pmid: 11733352
references.citation: J Gastrointest Surg. 2013 Jul;17(7):1181-7
references.pmid: 23609140
references.citation: Hum Mol Genet. 2002 Jun 15;11(13):1497-504
references.pmid: 12045203
references.citation: Bioessays. 2000 Nov;22(11):961-5
references.pmid: 11056471
references.citation: Cancer Res. 2002 Jan 1;62(1):277-82
references.pmid: 11782388
references.citation: Science. 2001 Aug 17;293(5533):1323-6
references.pmid: 11509733
references.citation: Oncogene. 2007 Dec 13;26(57):7825-32
references.pmid: 17599048
references.citation: Oncology. 1997 Mar-Apr;54(2):158-65
references.pmid: 9075789
references.citation: Cancer Res. 2002 Jun 15;62(12):3503-6
references.pmid: 12067995
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9248-51
references.pmid: 10430928
references.citation: Genes Cancer. 2010 Aug;1(8):822-35
references.pmid: 21127729
references.citation: J Gastrointest Surg. 2010 Feb;14 Suppl 1:S75-80
references.pmid: 19756878
references.citation: Nature. 1998 Jan 8;391(6663):184-7
references.pmid: 9428765
references.citation: Nat Rev Cancer. 2009 Aug;9(8):563-75
references.pmid: 19629071
references.citation: Mol Endocrinol. 2007 Dec;21(12):3039-49
references.pmid: 17761947
references.citation: Br J Cancer. 1999 Apr;80(1-2):70-2
references.pmid: 10389980
references.citation: Mol Genet Genomics. 2005 Apr;273(2):184-96
references.pmid: 15731909
references.citation: Cancer Res. 1994 Jan 1;54(1):291-6
references.pmid: 8261454
references.citation: Oncogene. 2003 Jul 24;22(30):4752-6
references.pmid: 12879020
references.citation: Nature. 2001 May 17;411(6835):342-8
references.pmid: 11357141
references.citation: Nature. 2005 Apr 14;434(7035):843-50
references.pmid: 15829953
references.citation: Clin Transl Oncol. 2009 Jul;11(7):411-27
references.pmid: 19574199
references.citation: Development. 2000 Apr;127(7):1467-75
references.pmid: 10704392
references.citation: Cancer Sci. 2012 Nov;103(11):1979-84
references.pmid: 22845557
references.citation: Cancer Res. 2009 Jul 1;69(13):5285-8
references.pmid: 19549904
references.citation: Am J Gastroenterol. 2010 Jun;105(6):1258-64; author reply 1265
references.pmid: 20051941
references.citation: Pediatr Surg Int. 2006 Jan;22(1):72-7
references.pmid: 16283335